GENERINI, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 3.433
EU - Europa 2.090
AS - Asia 641
SA - Sud America 44
OC - Oceania 39
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.265
Nazione #
US - Stati Uniti d'America 3.424
RU - Federazione Russa 765
PL - Polonia 415
IE - Irlanda 230
SG - Singapore 222
HK - Hong Kong 219
SE - Svezia 215
IT - Italia 141
CN - Cina 90
UA - Ucraina 81
DE - Germania 72
FI - Finlandia 57
BR - Brasile 42
GB - Regno Unito 39
TR - Turchia 39
AU - Australia 38
FR - Francia 24
IN - India 24
CH - Svizzera 19
JO - Giordania 19
AT - Austria 11
CA - Canada 8
VN - Vietnam 8
CI - Costa d'Avorio 7
KR - Corea 6
ID - Indonesia 5
AL - Albania 4
NL - Olanda 3
SC - Seychelles 3
ZA - Sudafrica 3
BG - Bulgaria 2
ES - Italia 2
JP - Giappone 2
LT - Lituania 2
LU - Lussemburgo 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BE - Belgio 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.265
Città #
Santa Clara 988
Warsaw 415
Fairfield 344
Chandler 295
Dublin 230
Ashburn 195
Hong Kong 168
Woodbridge 144
Jacksonville 130
Cambridge 129
Seattle 123
Wilmington 120
Singapore 116
Houston 86
Princeton 61
Buffalo 58
Medford 48
Boardman 44
Ann Arbor 41
Altamura 40
Beijing 37
Izmir 37
Melbourne 37
Lawrence 35
Boston 26
Shanghai 23
Paris 20
Bern 18
Mumbai 18
New York 18
Florence 17
San Diego 17
Moscow 16
Kent 13
Vienna 11
Yubileyny 11
Milan 9
Dong Ket 8
Los Angeles 8
Munich 8
West Jordan 8
Abidjan 7
Norwalk 6
Jakarta 5
Salerno 5
Seoul 5
Andover 4
Greenwich 4
Hillsboro 4
São Paulo 4
Toronto 4
Auburn Hills 3
Falkenstein 3
Falls Church 3
Frankfurt Am Main 3
Giessen 3
Newark 3
Parma 3
Phoenix 3
Pune 3
Rome 3
San Mateo 3
Americana 2
Amman 2
Ankara 2
Barcelona 2
Bari 2
Bologna 2
Bremen 2
Brooklyn 2
Caserta 2
Dearborn 2
Guangzhou 2
Hounslow 2
Indianapolis 2
Itabira 2
Langen 2
London 2
Montréal 2
Segrate 2
Tappahannock 2
The Dalles 2
Tokyo 2
Turin 2
Verona 2
'Asir Region 1
Ahmedabad 1
Almaty 1
Araranguá 1
Araras 1
Auckland 1
Belo Horizonte 1
Belém 1
Bishkek 1
Brussels 1
Bryant 1
Bucharest 1
Cabo de Santo Agostinho 1
Canoas 1
Cape Town 1
Totale 4.312
Nome #
[Peripheral nervous system in limited systemic sclerosis]. 261
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 257
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 248
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. 143
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 143
DRESS syndrome in a patient with chronic hepatic encephalopathy. 143
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. 137
Screening of distress among hospitalized patients in a department of internal medicine. 137
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 136
Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. 136
Oxidative stress in Systemic Sclerosis. 135
Estrogens and neuropeptides in Raynaud's phenomenon. 134
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. 130
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 125
Somatostatin-induced modulation of inflammation in experimental arthritis 121
Longitudinal ultrasound and clinical follow-up of Baker's cysts injection with steroids in knee osteoarthritis. 119
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 119
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 116
Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. 113
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 113
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 111
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 109
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 108
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 107
Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. 106
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. 106
Current Treatment Options in Raynaud's Phenomenon. 106
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 105
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 104
NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. 101
Evidence for the prevention of enthesitis in HLA-B27/hβ(2) m transgenic rats treated with a monoclonal antibody against TNF-α 98
Evidence of immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis. 94
The loss of endothelium dependent vascular tone control in systemic sclerosis. 93
Postural and kinesiologic evaluation in patients with early ankylosing spondylitis. 93
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 92
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. 91
NEPRILYSIN LEVELS IN PLASMA AND SYNOVIAL FLUID OF JUVENILE IDIOPATHIC ARTHRITIS PATIENTS. RHEUMATOL INT. 2005 JUN;25(5):336-40. EPUB 2004 MAR 3. 90
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. 89
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. 89
Raynaud's phenomenon and vascular disease in systemic sclerosis. 87
Vasculitides secondary to systemic diseases. 87
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). 86
Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades. 86
Evidence for hyaluronan production in the air pouch model in rats. 85
Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review. 85
A Sonographic (Us) Evaluation Of Ligaments Of Sacroiliac Joint In Healthy Subjects 84
TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats 82
Neuropeptides and steroid hormones in arthritis. 81
The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis. 68
Therapy of spondylarthropathy in inflammatory bowel disease. 66
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 66
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. 63
Raynaud's phenomenon and systemic sclerosis. 62
Systemic sclerosis. A clinical overview. 60
Iliopsoas bursitis in rheumatoid arthritis. 60
New approaches to Raynaud's phenomenon [corrected]. 56
Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels. 56
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. 55
Erratum: "The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn) (Clinical and Experimental Rheumatol (2005) vol. 23 (5) (671-677)) 55
Totale 6.288
Categoria #
all - tutte 17.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 0 0 0 0 0 0 64 17
2020/2021488 46 37 40 45 22 66 13 41 41 65 29 43
2021/2022354 10 37 10 11 8 15 13 15 15 13 92 115
2022/20231.019 105 153 39 102 86 188 124 53 96 15 32 26
2023/2024387 14 39 63 18 34 67 15 85 2 16 25 9
2024/20252.506 80 263 189 427 866 340 30 99 137 54 21 0
Totale 6.288